W

Weight Loss Drug Stocks

$DIETDRUGSddub Advisors

About Weight Loss Drug Stocks

This portfolio gives exposure to companies that are developing, producing, or researching weight-loss drugs such as Ozempic and Zepbound. These drugs not only promote a sustainable reduction in body weight, but they also significantly diminish the risks associated with obesity-related health concerns, including heart disease and diabetes.

Learn More

Asset Breakdown

LLY44.71%
NVO19.74%
AMGN12.71%

Download to see all

See all holdings and assets in the dub app

About the Creator

dub Advisors LLC is an SEC registered investment advisor. As an SEC registered investment advisor, we are legally obligated to act solely in the best interests of our clients, prioritizing our clients' needs above our own, and avoiding any conflicts of interest when providing investment advice to you.

For more information about dub Advisors, please see our ADV

Activity

Total Rebalances5
Last RebalanceOct 13, 2026

Posts by Creator

See all
Changes:LLY +7.5%AMGN +2.4%VKTX +2.0%PFE +1.4%NVO -10.0%

$DIETDRUGS Trim NVO, add to VKTX and PFE.

Premium content is hidden.

Premium content is hidden.

Download to see all

See all trades and insights on the dub app